LSV Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Buy
46,704
+40
+0.1% +$13.1K 0.03% 358
2025
Q4
$16.4M Buy
46,664
+38,400
+465% +$13M 0.04% 335
2025
Q3
$2.67M Buy
8,264
+7,364
+818% +$2.29M 0.01% 544
2025
Q2
$350K Sell
900
-40
-4% -$16.1K ﹤0.01% 709
2025
Q1
$409K Buy
940
+20
+2% +$8.03K ﹤0.01% 709
2024
Q4
$339K Buy
920
+20
+2% +$8.37K ﹤0.01% 714
2024
Q3
$468K Sell
900
-41,000
-98% -$21.9M ﹤0.01% 706
2024
Q2
$22.7M Hold
41,900
0.05% 315
2024
Q1
$21.7M Hold
41,900
0.05% 330
2023
Q4
$19.8M Hold
41,900
0.04% 343
2023
Q3
$18.2M Hold
41,900
0.04% 330
2023
Q2
$18.6M Sell
41,900
-3,047
-7% -$1.41M 0.04% 328
2023
Q1
$20.7M Hold
44,947
0.05% 306
2022
Q4
$23.1M Hold
44,947
0.05% 290
2022
Q3
$20.4M Sell
44,947
-600
-1% -$287K 0.05% 300
2022
Q2
$22M Sell
45,547
-1,400
-3% -$693K 0.05% 301
2022
Q1
$23.1M Sell
46,947
-100
-0.2% -$45.7K 0.04% 317
2021
Q4
$21.8M Sell
47,047
-150,524
-76% -$63.3M 0.04% 344
2021
Q3
$73.7M Sell
197,571
-16,420
-8% -$6.24M 0.13% 192
2021
Q2
$81.7M Sell
213,991
-4,050
-2% -$1.55M 0.14% 191
2021
Q1
$78.3M Buy
218,041
+2,400
+1% +$772K 0.13% 194
2020
Q4
$69.2M Buy
215,641
+4,500
+2% +$1.38M 0.13% 201
2020
Q3
$56.7M Buy
211,141
+17,166
+9% +$4.62M 0.12% 211
2020
Q2
$51M Buy
193,975
+32,758
+20% +$8.74M 0.11% 222
2020
Q1
$36.6M Buy
161,217
+117,170
+266% +$31.9M 0.09% 227
2019
Q4
$13.3M Hold
44,047
0.02% 431
2019
Q3
$10.6M Sell
44,047
-330
-0.7% -$90.4K 0.02% 451
2019
Q2
$12.5M Sell
44,377
-80
-0.2% -$21.9K 0.02% 430
2019
Q1
$12.8M Sell
44,457
-34,170
-43% -$9.88M 0.02% 433
2018
Q4
$20.6M Sell
78,627
-365,190
-82% -$100M 0.04% 354
2018
Q3
$122M Sell
443,817
-1,230,200
-73% -$319M 0.18% 155
2018
Q2
$398M Sell
1,674,017
-238,940
-12% -$55.3M 0.62% 40
2018
Q1
$420M Sell
1,912,957
-559,142
-23% -$131M 0.67% 40
2017
Q4
$556M Sell
2,472,099
-235,429
-9% -$50.1M 0.88% 16
2017
Q3
$514M Sell
2,707,528
-5,261
-0.2% -$1M 0.85% 18
2017
Q2
$510M Sell
2,712,789
-13,471
-0.5% -$2.42M 0.91% 18
2017
Q1
$451M Sell
2,726,260
-175,050
-6% -$27.8M 0.82% 19
2016
Q4
$417M Sell
2,901,310
-250,648
-8% -$33.6M 0.77% 25
2016
Q3
$395M Sell
3,151,958
-100,470
-3% -$13M 0.78% 20
2016
Q2
$427M Sell
3,252,428
-130,657
-4% -$17.9M 0.87% 19
2016
Q1
$470M Sell
3,383,085
-57,390
-2% -$7.67M 0.99% 15
2015
Q4
$480M Sell
3,440,475
-193,916
-5% -$26.7M 1.04% 17
2015
Q3
$509M Sell
3,634,391
-227,190
-6% -$34.1M 1.14% 13
2015
Q2
$634M Sell
3,861,581
-697,129
-15% -$111M 1.31% 8
2015
Q1
$704M Sell
4,558,710
-122,836
-3% -$17.5M 1.46% 7
2014
Q4
$588M Sell
4,681,546
-122,337
-3% -$15.1M 1.22% 9
2014
Q3
$575M Sell
4,803,883
-7,160
-0.1% -$821K 1.26% 10
2014
Q2
$518M Buy
4,811,043
+48,160
+1% +$4.96M 1.15% 10
2014
Q1
$474M Sell
4,762,883
-17,641
-0.4% -$1.6M 1.11% 12
2013
Q4
$442M Buy
4,780,524
+884,046
+23% +$78.6M 1.04% 14
2013
Q3
$326M Buy
3,896,478
+49,704
+1% +$4.26M 0.83% 27
2013
Q2
$315M Buy
+3,846,774
New +$288M 0.84% 25

Other funds holding ELV

LSV Asset Management's ELV Position: Q1 2026 in Review

LSV Asset Management increased its Elevance Health (ELV) stake by 0.09% in Q1 2026, buying an estimated $13.1K and bringing the position to 46,704 shares worth $13.7M. The position accounts for 0.03% of the portfolio, ranked #358.

LSV Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $704M in Q1 2015. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • LSV Asset Management held 46,704 shares of Elevance Health worth $13.7M as of Q1 2026.
  • LSV Asset Management bought 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
  • Elevance Health made up 0.03% of LSV Asset Management's portfolio in Q1 2026, its #358 holding.
  • LSV Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • LSV Asset Management's Elevance Health position peaked at $704M in Q1 2015.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on LSV Asset Management's 13F filing for Q1 2026, filed 11 May 2026.